{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:20:06Z","timestamp":1790882406382,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04189-x","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:06:10Z","timestamp":1748235970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The relationship between multiple plasma biomarker levels and renal disease activity in Fabry disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Seyda Gul","family":"Ozcan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necmi","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mevlut Tamer","family":"Dincer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Atli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Bolayirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Ergul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kultigin","family":"Turkmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Trabulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhan","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"issue":"4","key":"4189_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2133.1898.tb16317.x","volume":"10","author":"W Anderson","year":"1898","unstructured":"Anderson W. A case of angeio-keratoma. Br J Dermatol. 1898;10(4):113\u20137.","journal-title":"Br J Dermatol"},{"key":"4189_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF01986897","volume":"43","author":"A Neisser","year":"1898","unstructured":"Neisser A, Fabry J. Arch Dermatol Syph. 1898;43:187\u2013200.","journal-title":"Arch Dermatol Syph"},{"key":"4189_CR3","unstructured":"Desnick R, \u03b1-Galactosidase A. deficiency: Fabry disease. The metabolic and molecular bases of inherited disease. 1995:2741-84."},{"key":"4189_CR4","doi-asserted-by":"crossref","unstructured":"Mauhin W, Lidove O, Masat E, Mingozzi F, Mariampillai K, Ziza J-M et al. Innate and adaptive immune response in Fabry disease. JIMD Reports, Volume 22: Springer; 2015. pp. 1\u201310.","DOI":"10.1007\/8904_2014_371"},{"issue":"4","key":"4189_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","volume":"123","author":"A Ortiz","year":"2018","unstructured":"Ortiz A, Germain DP, Desnick RJ, Politei J, Mauer M, Burlina A, et al. Fabry disease revisited: management and treatment recommendations for adult patients. Mol Genet Metab. 2018;123(4):416\u201327.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"4189_CR6","first-page":"811","volume":"1841","author":"MJ Ferraz","year":"2014","unstructured":"Ferraz MJ, Kallemeijn WW, Mirzaian M, Moro DH, Marques A, Wisse P, et al. Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses. Biochim Et Biophys Acta (BBA)-Molecular Cell Biology Lipids. 2014;1841(5):811\u201325.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Cell Biology Lipids"},{"issue":"1","key":"4189_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1681\/ASN.2020040487","volume":"32","author":"SJ Schrauben","year":"2021","unstructured":"Schrauben SJ, Shou H, Zhang X, Anderson AH, Bonventre JV, Chen J, et al. Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the chronic renal insufficiency cohort (CRIC) study. J Am Soc Nephrol. 2021;32(1):115\u201326.","journal-title":"J Am Soc Nephrol"},{"key":"4189_CR8","unstructured":"Fabry mutants list [Available from. http:\/\/fabry-database.org\/mutants\/"},{"issue":"1","key":"4189_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/ejechocard\/jer176","volume":"13","author":"A Barbieri","year":"2012","unstructured":"Barbieri A, Bursi F, Mantovani F, Valenti C, Quaglia M, Berti E, et al. Left ventricular hypertrophy reclassification and death: application of the recommendation of the American society of echocardiography\/European association of echocardiography. Eur Heart Journal\u2013Cardiovascular Imaging. 2012;13(1):109\u201317.","journal-title":"Eur Heart Journal\u2013Cardiovascular Imaging"},{"issue":"2","key":"4189_CR10","first-page":"51","volume":"10","author":"A Mehta","year":"2012","unstructured":"Mehta A, Pastores GM, Pintos-Morell G. Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease. Curr Med Literature. 2012;10(2):51.","journal-title":"Curr Med Literature"},{"issue":"5","key":"4189_CR11","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1681\/ASN.2004100854","volume":"16","author":"BA Perkins","year":"2005","unstructured":"Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum Cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol. 2005;16(5):1404\u201312.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"4189_CR12","first-page":"437","volume":"20","author":"S Feriozzi","year":"2007","unstructured":"Feriozzi S, Germain DP, Di Vito R, Legrand A, Ricci R, Barbey F. Cystatin C as a marker of early changes of renal function in Fabry nephropathy. J Nephrol. 2007;20(4):437\u201343.","journal-title":"J Nephrol"},{"issue":"10","key":"4189_CR13","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cjca.2015.10.033","volume":"32","author":"K-H Chen","year":"2016","unstructured":"Chen K-H, Chien Y, Wang K-L, Leu H-B, Hsiao C-Y, Lai Y-H, et al. Evaluation of Proinflammatory prognostic biomarkers for Fabry cardiomyopathy with enzyme replacement therapy. Can J Cardiol. 2016;32(10):1221. e1-. e9.","journal-title":"Can J Cardiol"},{"issue":"20","key":"4189_CR14","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1093\/hmg\/ddv291","volume":"24","author":"MD Sanchez-Ni\u00f1o","year":"2015","unstructured":"Sanchez-Ni\u00f1o MD, Carpio D, Sanz AB, Ruiz-Ortega M, Mezzano S, Ortiz A. Lyso-Gb3 activates Notch1 in human podocytes. Hum Mol Genet. 2015;24(20):5720\u201332.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"4189_CR15","first-page":"101","volume":"6","author":"Y Xia","year":"2007","unstructured":"Xia Y, Frangogiannis NG. MCP-1\/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm Allergy-Drug Targets (Formerly Curr Drug Targets-Inflammation Allergy)(Discontinued). 2007;6(2):101\u20137.","journal-title":"Inflamm Allergy-Drug Targets (Formerly Curr Drug Targets-Inflammation Allergy)(Discontinued)"},{"issue":"3","key":"4189_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","volume":"61","author":"C Baeck","year":"2012","unstructured":"Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, et al. Pharmacological Inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut. 2012;61(3):416\u201326.","journal-title":"Gut"},{"issue":"21","key":"4189_CR17","doi-asserted-by":"publisher","first-page":"e009098","DOI":"10.1161\/JAHA.118.009098","volume":"7","author":"H Yogasundaram","year":"2018","unstructured":"Yogasundaram H, Nikhanj A, Putko BN, Boutin M, Jain-Ghai S, Khan A, et al. Elevated inflammatory plasma biomarkers in patients with Fabry disease: a critical link to heart failure with preserved ejection fraction. J Am Heart Association. 2018;7(21):e009098.","journal-title":"J Am Heart Association"},{"issue":"12","key":"4189_CR18","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.bbamem.2006.05.027","volume":"1758","author":"T Kolter","year":"2006","unstructured":"Kolter T, Sandhoff K. Sphingolipid metabolism diseases. Biochim Et Biophys Acta (BBA)-Biomembranes. 2006;1758(12):2057\u201379.","journal-title":"Biochim Et Biophys Acta (BBA)-Biomembranes"},{"key":"4189_CR19","doi-asserted-by":"crossref","unstructured":"Sandokji I, Greenberg JH, editors. Plasma and urine biomarkers of CKD: A review of findings in the CKiD study. Seminars in nephrology. Elsevier; 2021.","DOI":"10.1016\/j.semnephrol.2021.09.003"},{"issue":"3","key":"4189_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ymgme.2006.04.013","volume":"89","author":"A Vedder","year":"2006","unstructured":"Vedder A, Cox-Brinkman J, Hollak C, Linthorst G, Groener J, Helmond M, et al. Plasma Chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy. Mol Genet Metab. 2006;89(3):239\u201344.","journal-title":"Mol Genet Metab"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04189-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:06:13Z","timestamp":1748235973000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04189-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4189"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04189-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Istanbul Training and Research Hospital (approval no: 67) and conducted according to the Declaration of Helsinki. Informed consent was taken from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided informed consent for participation and publication of anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}